News:
- TENET i2c Competition at #inventures2022, (1st prize: $10,000)Zymedyne would like to congratulate CEO Chris Bladen on winning the “Engineering solutions for human and animal health” TENET i2c Competition at #inventures2022, (1st prize:…
- LIBI Podcast Supported by Rainforest AlbertaPeter Beaudoin Hosts Zymedyne CEO & Co-founder on the Leaders, Innovators & Big Ideas (LIBI) podcast. To listen, visit: https://www.podbean.com/ew/pb-b7h2f-11b0817
- Zymedyne ACS Chemical Neuroscience PublicationZymedyne is excited to report some of their groundbreaking research in the leading Journal ACS Chemical Neuroscience! Link to publication: https://pubs.acs.org/doi/10.1021/acschemneuro.1c00765?ref=pdf
- Mitacs Accelerate Industrial Postdoc awarded to Dr. Ketul Patel, Zymedyne’s PostDoc Organic ChemistZymedyne Therapeutics is pleased to announce that a Mitacs Accelerate Industrial Postdoc has been awarded to Dr Ketul Patel to conduct structure-activity…
- Zymedyne Therapeutics awarded 1st place in the EntrepreNeuro Pitch Competition from Campus Alberta Neuroscience.Zymedyne is pleased to announce that Co-founder Dr. Chris Bladen was awarded 1st place in the “EntrepreNeuro Pitch Competition” from Campus Alberta…
- Parex Innovation FellowshipZymedyne is pleased to announce that Co-founder Dr.Gerald Zamponi has received a “Parex Innovation Fellowship” from the University of Calgary for his…
- Zymedyne – University of Calgary collaboration receives major AICE funding award from Alberta InnovatesZymedyne Therapeutics is pleased to announce that a 3 year $600,000 AICE Concepts grant from Alberta Innovates has been secured to support critical…
- Canadian Pain Society: Distinguished Career AwardCongratulations to Zymedyne’s Chief Science Officer & Co-Founder, Dr. Gerald Zamponi for his long standing contributions to pain research and management! Link…
- UCEED OPPORTUNITY HEALTH FUND AWARDZymedyne Therapeutics is pleased to announce it has been awarded a UCEED Opportunity Fund Award from University of Calgary. Implemented by Innovate Calgary,…
- NAI Fellow – Dr. ZamponiZymedyne is very proud to congratulate Co-founder Dr. Gerald Zamponi on being inducted as Fellow of the 2020 class of National Academy…
Zymedyne in the media:
University of Calgary/UCEED
Zymedyne is one company #UCalgary’s UCeed is pursuing investments in. Its technology works at the molecular level to prevent the body from undergoing certain changes that cause chronic pain, helping a broad range of patients. Learn more: http://ow.ly/Ihqw50Dg6qn
Posted by University of Calgary on Monday, January 25, 2021
Campus Alberta Neuroscience